Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04023773 · ClinicalTrials.gov registry record · NA
Sequential Hypo- and Normo-thermic Perfusion to Preserve Extended Criteria Donor Livers for Transplantation
A NA study of Liver Transplantation, sponsored by Koji Hashimoto.
- Active
- Registry status
- NA
- Development phase
- 18
- Enrollment target
- 1
- Study location
NCT04023773 is a NA study of Liver Transplantation that is active but no longer recruiting, run by Koji Hashimoto. The registered enrollment target is 18 participants, below the 322-participant average among 12 other Liver Transplantation trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04023773, a NA study of Liver Transplantation, is active but no longer recruiting, sponsored by Koji Hashimoto.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
- 1
- Study location
Study Summary
Hypothermic machine perfusion (HMP) has been shown to be beneficial to preserve extended criteria donor (ECD) livers for transplantation. Normothermic machine perfusion (NMP) had the same benefits and also the convenience on liver quality assessment. The investigators proposed to do sequential HMP (1-4 hours) and NMP (1-14 hours) on 18 ECD transplanted human livers by using an institutional-developed perfusion device for liver transplantation.
Conditions Studied
Interventions
- DEVICE Liver Machine Perfusion (MP) device
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2021-05-01 |
| Est. Completion | 2027-01-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04023773
The ClinicalTrials.gov registry entry for NCT04023773 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 322-participant average among 12 other Liver Transplantation trials with a reported enrollment target (94% lower). The listed sponsor is Koji Hashimoto, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Liver Transplantation appearing as the primary indexed condition, and to 1 intervention - of which Liver Machine Perfusion (MP) device is the first listed.
NCT04023773 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04023773 about?
NCT04023773 is a clinical study titled "Sequential Hypo- and Normo-thermic Perfusion to Preserve Extended Criteria Donor Livers for Transplantation". Hypothermic machine perfusion (HMP) has been shown to be beneficial to preserve extended criteria donor (ECD) livers for transplantation. Normothermic machine perfusion (NMP) had the same benefits and also the convenience on liver quality assessment. The investigators proposed to do sequential HMP (...
What is the current status of trial NCT04023773?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 18 participants. The study started on 2021-05-01. Estimated completion is 2027-01-30.
What conditions does trial NCT04023773 study?
This clinical trial studies the following conditions: Liver Transplantation.
What interventions are being tested in trial NCT04023773?
The interventions under investigation include: Liver Machine Perfusion (MP) device (DEVICE).
Who is sponsoring clinical trial NCT04023773?
This trial is sponsored by Koji Hashimoto, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04023773 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mediterranean Diet Post-liver Transplantation
RECRUITING · NA
-
Continued Access Study to Evaluate Performance of the Organ Recovery Systems _LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant (PILOT™_CA)
ACTIVE NOT RECRUITING · NA
-
Study of Resistance Strengthening Versus Ambulation Post-Liver Transplant
COMPLETED · NA
-
HOPE Against Cancer Recurrence in HCC
RECRUITING · Phase 4
-
Reducing Pain With Methadone and Ketamine in Liver Transplant
RECRUITING · Phase 4
-
Immune Tolerance Induction After Liver Transplantation
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.